The 5-Hydroxytryptamine Receptor 4 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 4 targeted therapeutics, complete with analysis by ...

The 5-Hydroxytryptamine Receptor 1 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1 targeted therapeutics, complete with analysis by ...

9月19日，中国中医药行业唯一国家级报纸、中国中医药界最具影响力和传播力媒体《中国中医药报》专题报道——《保定中药：为“双心疾病”治疗提供中药方案》。该报道详细阐述了保定中药在推动中药现代化、促进“冠心静双心同治”理念实践中的杰出贡献，特别是对冠心静 ...

SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and ...

A new study has estimated more than five million Americans could reap benefits if the Food and Drug Administration approved ...

Fintel reports that on September 10, 2024, Truist Securities initiated coverage of Longboard Pharmaceuticals (NasdaqGM:LBPH) ...

1 Department of Neurology, Danish Headache Centre, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark 2 ...

Although many studies were carried out to evaluate the role of melatonin in GERD based on its effect in alleviation of GERD symptoms only, the review of literature showed that no previous studies ...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the FDA ...

冠心静成功入选《河北省生物医药产业重点产品目录（第一批）》保定中药为“双心疾病”治疗提供中药方案近日，为了充分落实河北省委、省政府决策部署，加快重点产品推广应用，推动生物医药产业高质量发展，河北省工业和信息化厅、河北省卫生健康委员会、河北省药品监督管 ...